Abbott to Collaborate on Rapid Molecular Test to Identify Serious Infections in Bones and Joints
March 5, 2012
Abbott Park, Illinois — Abbott announced today it will collaborate with Genetics Laboratory, Inc. (GenLab) on the development of a molecular diagnostic test that will be designed to rapidly detect microorganisms that cause orthopedic infections. Under terms of the agreement, Abbott, in conjunction with GenLab, will develop and commercialize the new assay for use on [...]
Smiths Detection Unveils Mobile, Low-Cost Cargo Scanner
March 5, 2012
London, UK - Smiths Detection has unveiled a next-generation X-ray cargo scanner that is smaller, more cost effective and designed for easier operation in the field than traditional mobile systems. Unlike standard radioactive source-based systems, the HCVM e uses the power of a 4MeV X-ray accelerator and can scan loaded cargo containers with a steel [...]
Bispecific Antibody Binding Data Generated Using Living Cells to be Presented at PEGS 2012
March 5, 2012
Bonn, Germany – SAW Instruments, developer of the innovative sam® family of biosensors for real-time, label-free assays using living cells, will be exhibiting at this year’s PEGS protein engineering meeting in Boston, USA from 30 April until 4 May 2012. SAW will showcase its new sam®X system (booth #12), which is optimised for more flexible [...]
PICARRO NAMED 2012 ENERGY INNOVATION PIONEER BY IHS CERA
March 5, 2012
Santa Clara, CA - Picarro, Inc., the world's leading provider of instruments for carbon and water cycle measurements, has been named a 2012 Energy Innovation Pioneer by IHS CERA, the leading global source of information and analytics on energy markets, geopolitics and industry trends. IHS CERA selects companies for the award based on creativity, feasibility [...]
March 2, 2012
Ann Arbor, MI – Rubicon Genomics, Inc., a company developing and commercializing sample-specific pre-analytical processes to improve the capabilities and performance of DNA and RNA analytical platforms, today announced that it has selected Velesco Pharmaceutical Services to manufacture the TransPLEX® kits it will be supplying for use with Agendia’s breast cancer diagnostics. Velesco is a [...]
Abbott’s STARLIMS Business Acquires Distribution Partners to Build International Presence
March 2, 2012
Abbott Park, Illinois (NYSE: ABT) — As part of a series of strategic moves to build its laboratory information management system (LIMS) business in Europe and emerging markets in Latin America and Africa, STARLIMS Technologies, an Abbott company, has announced the acquisition of several longtime distribution partners. These acquisitions include STARLIMS's French distributor Varilab; operations [...]
LadaTech announces Illumina Found to Infringe Patent
March 2, 2012
LARCHMONT, N.Y.--LadaTech LLC, which is jointly owned by GlaxoSmithKline (GSK) and IP Finance Holdings, announced today that a jury has found that Illumina Inc. (ILMN) has infringed a patent owned by LadaTech covering essential aspects of the Solexa DNA sequencing technology in a major patent infringement lawsuit in Delaware. (LadaTech, LLC v. Illumina, Inc. and [...]
Prognosys Launches RNA-Seq Study-Level Statistical Module for the Voila! Analysis Platform
March 2, 2012
La Jolla, CA RNA sequencing is rapidly becoming a routine tool for many researchers. The data from RNA-Seq experiments is more expansive and detailed than from other technologies for transcriptome analysis, including microarrays. However, the optimal analysis of RNA-Seq datasets presents bioinformatics challenges for general users. The Voila! cloud-based data analysis service offered by Prognosys [...]
Noodle Tensile Fixture for Perfect Pasta!
March 2, 2012
Middleboro, MA – Brookfield Engineering Laboratories offers the TA-NTF Noodle Tensile Fixture for their CT3 Texture Analyzer. The Noodle Texture Fixture is designed to test the extensibility and tensile breaking strength of noodles. pasta, and other similar food items. Brookfield will work with the customer to develop the testing methodology required to provide consistent test [...]
MOCON Announces Record Sales for the Fourth Quarter and Year Ended 2011
March 2, 2012
MINNEAPOLIS - MOCON, Inc. reported its operating results for the fourth quarter and year ended December 31, 2011. Net sales for the fourth quarter 2011 were $9,741,000, a new record for the Company, and an increase of 4 percent compared to $9,355,000 for the fourth quarter 2010. Net income for the fourth quarter 2011 was [...]
